Wave Life Sciences (WVE) Treasury Shares (2015 - 2025)

Wave Life Sciences (WVE) has 12 years of Treasury Shares data on file, last reported at $3.2 million in Q2 2026.

• Quarterly Treasury Shares fell 18.49% year-over-year to $3.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.2 million (down 18.49% YoY) and the FY2025 annual result came in at $3.9 million, changed 0.0% from the prior year.
• Treasury Shares slipped to $3.2 million in Q2 2026, from $3.9 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.9 million in Q1 2022 to a low of $3.2 million in Q2 2026.
• A 5-year average of $3.9 million and a median of $3.9 million in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares changed 0.0% — and 2026, when it retreated 18.49%.
• Tracing WVE's Treasury Shares over 5 years: stood at $3.9 million in 2022, then changed by 0.0% to $3.9 million in 2023, then changed by 0.0% to $3.9 million in 2024, then changed by 0.0% to $3.9 million in 2025, then retreated by 18.49% to $3.2 million in 2026.
• The last three Treasury Shares figures came in at $3.2 million (Q2 2026), $3.9 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.